The University of California, San Francisco has selected Atul Butte to lead its Institute for Computational Health Sciences, effective April 1. In addition to his role at UCSF, Butte also has been named executive director of clinical informatics for UC Health Sciences and Services. In this position, he will join in the ongoing development and implementation of a UC-wide data warehouse and analytic platform.
Butte is currently chief of Stanford University's Division of Systems Medicine and an associate professor of pediatrics at Stanford and Lucile Packard Children’s Hospital. Previously, he worked as a software engineer at Apple and Microsoft. He trained in computer science and medicine at Brown University and obtained his PhD in health sciences and technology from Harvard Medical School and the Massachusetts Institute of Technology. He has also founded several Bay Area biotech startup companies.
Nick Ecos has been appointed CEO of Biomatrica. Most recently Ecos served as vice president and general manager of licensing and commercial partnering at Thermo Fisher Scientific. He has 20 years of experience in the biotechnology and healthcare business, including positions at Life Technologies and Invitrogen.
Merilee Raines has joined Affymetrix's board of directors and will serve as a member of the audit committee. Raines served as CFO of Idexx Laboratories from 2003 until her retirement in 2013. Prior to this, she held various management positions at Idexx, including vice president of finance, treasurer, director of finance, and controller.
Vermillion said today that it has appointed Patrick Carpenter general manager of its CLIA laboratory business, Aspira Labs. Carpenter was previously vice president of operations at Miraca Life Sciences. Before that, he held positions at companies including Dianon Systems, VCA/Antech Diagnostics, and Quest Diagnostics.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.